Matthew Lorson, OD
NPI 1265094171 · Optometrist · Hutchinson, KS
Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Matthew Lorson, OD is a Optometrist provider in Hutchinson, KS (NPI 1265094171).
Provider details
- NPI number
- 1265094171
- Entity type
- Individual
- Primary specialty
- OptometristEye and Vision Services Providers
- Credential
- OD
- Sex
- Male
- Sole proprietor
- No
- License
- 2102 (KS)
Specialties & taxonomies
Eye and Vision Services Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
6 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,059 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 319 | $115 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 248 | $84 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 240 | $119 |
| Imaging of Retina92134 | 62 | $37 |
| Imaging of Optic Nerve92133 | 59 | $32 |
| Exam of Visual Field With Extended Testing92083 | 54 | $58 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 11 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 183 | 36 |
| Timolol Maleate | 56 | 14 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 35 | — |
| Brimonidine Tartrate | 34 | — |
| Bimatoprostbrand: Lumigan | 18 | — |
| Prednisolone Acetate | 17 | 12 |
| Cyclosporinebrand: Restasis | 16 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$229 across 3 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2019-07-01
- Last updated
- 2019-07-01
Frequently asked questions
- What is Matthew Lorson's NPI number?
- Matthew Lorson's National Provider Identifier (NPI) is 1265094171, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Matthew Lorson's specialty?
- Matthew Lorson is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).
- Where is Matthew Lorson located?
- Matthew Lorson's practice location on file with NPPES is 3120 N Plum St, Hutchinson, KS 67502-2918.
- What is Matthew Lorson's phone number?
- The practice phone number listed in the NPPES registry for Matthew Lorson is (620) 662-2355.
- Does Matthew Lorson accept Medicare?
- Matthew Lorson is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Matthew Lorson's NPI active?
- Yes — Matthew Lorson's NPI (1265094171) is active in the NPPES registry as of the last update on 2019-07-01.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.